News & Updates

Antipsychotic use for amphetamine-induced psychosis tied to longer hospital stay

Patients with amphetamine-induced psychosis (AIP) who have been treated with antipsychotics appear to have a longer length of stay (LOS) than those who did not receive such treatment, reports a study.

Real-world data highlight tofacitinib potential for irAE management in cancer patients

In a study presented at ESMO Asia 2023, tofacitinib, a rapidly acting JAK-STAT inhibitor with reported efficacy in the treatment of various autoimmune diseases, was effective for the management of difficult-to-treat immune-related adverse events (irAEs) and was well-tolerated in cancer patients, with only a few patients developing infectious events.

Add-on PCSK9 inhibitor cuts LDL-C by half, allows infrequent dosing in patients maxed out on statins

Injection with the novel, long-acting PCSK9 inhibitor recaticimab once every 3 months reduces LDL-cholesterol (LDL-C) levels by >50 percent compared with placebo in patients already maxed out on statins in the phase III REMAIN-2 trial.

Even seemingly healthy teens with high BMI at risk of early CKD

High body mass index (BMI) in late adolescence appears to be a risk factor for chronic kidney disease (CKD) in young adulthood, even for seemingly healthy individuals with a BMI that falls within the normal range but is closer to the upper limit, as reported in a study.

Real-world data favour etelcalcetide for treating SHPT in multiethnic Asians

Etelcalcetide proves beneficial in the real-world treatment of secondary hyperparathyroidism (SHPT) in multiethnic Asian haemodialysis patients, with the added advantage of reducing pill burden, as shown in a study from Singapore.

Exercise plus beetroot juice boosts heart function in women planning to conceive

Beetroot juice in combination with exercise may help improve cardiovascular function in women who are planning to have children, suggests a study.